Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in MYRIAD GENETICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 233,748 shares of MYGN (MYRIAD GENETICS INC), worth $1.1M as of 2026-Q1. The position was increased (+4.3% shares). MYGN represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.1M
Current Shares
233,748
Total Value Change
-$3.3M
Total Shares Change
+53,938
Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 233,748 |
+4.3% |
| $1.1M |
| 0.0% |
| $5.29 |
26 |
| 2025-Q4 | Increased | 224,133 | +11.6% | $1.4M | 0.0% | $6.17 | 28 |
| 2025-Q3 | Decreased | 200,873 | -46.5% | $1.5M | 0.0% | $7.24 | 0 |
| 2025-Q2 | Increased | 375,595 | +25.5% | $2M | 0.0% | $5.25 | 32 |
| 2025-Q1 | Increased | 299,256 | +4.9% | $2.7M | 0.0% | $8.88 | 28 |
| 2024-Q4 | Increased | 285,229 | +43.9% | $3.9M | 0.0% | $13.63 | 36 |
| 2024-Q3 | Increased | 198,256 | +10.3% | $5.4M | 0.0% | $26.46 | 30 |
| 2024-Q2 | Increased | 179,810 | +92.6% | $4.4M | 0.0% | $24.46 | 42 |